Regional Events and Mentions
By honoring researchers, engineers, and data scientists, we leverage regional convergence to place our community in the context of international breakthroughs for human health.
If you have an event, program, or regional news to share,
please email email@example.com.
New York City Regional Innovation Node - 6th Annual Network Meeting
July 10, New York, NY
Nodes, sites, students, entrepreneurs, and industry members are invited to exchange ideas in innovation and entrepreneurship and share best practices through workshops, panels, roundtables and more! You will hear from National Science Foundation (NSF) keynote speakers to learn about new NSF ICorps opportunities and programs.
NYCRIN will also feature former I-Corps teams in a Venture Showcase and Lightning Pitch session. The full day event has been curated for a diverse group of professionals to share and learn about the ecosystem, so all industries and experiences are welcome! The meeting is free to attend! Food and refreshments will be served.
NYCRIN Summer 2018 Regional I-Corps Short Course
Application Deadline: July 16, 2018
This Short Course is an accelerated 2-week program utilizing the Lean Launchpad Methodology. Teams will ‘Get out of the Building’ and talk to potential customers to discover how their technology could effectively ‘solve’ customers’ unmet needs. The curriculum will focus on customer development and the Right Hand Side of the Business Model Canvas.
Kickoff: August 6 & 7 2018
Webex: Monday, August 13, 2018
Finale: Friday, August 17, 2018
Kickoff and Finale will take place at the CUNY Graduate Center in NYC.
Rare Innovation Challenge
Sanofi-Genzyme Invites you to Partner
Submission Deadline: July 27, 2018
Patients with rare diseases often spend years of their lives meeting physician after physician and, despite best efforts, remain without an explanation for their debilitating symptoms.
Sanofi Genzyme invites you to partner with them to reduce the time to diagnosis for rare diseases. They are looking for innovative digital health, medtech or technology companies (startups or otherwise) that can apply their technologies to the challenges that keep patients from receiving accurate, timely diagnoses of rare diseases.
FFMI fastPACE; Train-the-Trainer for fastPACE
September 20-21: University of Michigan Workshop
September 28: Conference Call 3-4:30 p
October 5: Conference Call 3-4:30 p
October 12: Conference Call 3-4:30 p
October 19: Live Stream/University of Michigan 12-5 p
The University of Michigan’s Fast Forward Medical Innovation (FFMI) team is working in close partnership with U-M’s CTSA organization MICHR to support educational programs for all learners on the commercialization of biomedical research and innovation.
The FFMI fastPACE program, based on LEAN Startup principles, is customized to help busy clinician-researchers and scientists better understand how to successfully put their research innovations on viable paths to commercialization through a process of accelerated value proposition analysis and customer discovery.
Starting September 2018, FFMI will launch its 9th cohort of this 4-week biomedical commercialization and innovation course designed for the busy medical academician with an early stage biomedical product idea. This course blends in-person and online education to help faculty researchers and clinicians prepare a successful business case for funding and partnerships.
In parallel to fastPACE, participating CTSA organizations will have the opportunity to observe our expert teaching team and learn how to launch this program at their home institutions providing their biomedical faculty with the knowledge and tools necessary to navigate the initial process of innovation and commercialization. This 4-week course is a hands-on collaborative learning experience.
News and Articles
Sapience Therapeutics Enters into Drug Discovery Pact with the University of Bath
April 5, 2018 - Press Release
HARRISON, NY -- (Marketwired) -- 04/05/18 -- Sapience Therapeutics, Inc., a biotechnology company focused on discovering and developing peptide therapeutics to address difficult to treat oncology indications, announced today that it has entered into a research collaboration agreement with the University of Bath to discover new therapeutic agents.
"We are pleased to be collaborating with Dr. Jody Mason and the University of Bath to discover promising new oncology drugs. Jody has spent over 15 years developing and refining this drug discovery approach and has demonstrated a capacity to generate promising leads against selected targets. This collaboration gives Sapience the opportunity to supplement our ST101 program with a broad pipeline of new peptide therapeutics targeting oncogenic and immune-modulatory protein-protein interactions," said Dr. Barry Kappel, founder and chief executive officer of Sapience Therapeutics. more
Profectus BioSciences leases labs at Pearl River campus
May 24, 2018 Article
Profectus BioSciences, a vaccine maker that focuses on infectious diseases and associated cancers, has leased 39,455 square feet of space for labs and offices at the former Pfizer research campus in Pearl River.
The landlord, Los Angeles-based Industrial Realty Group (IRG), announced the new tenant and a new name for the campus, the New York Center for Innovation.